# Expanded-access use of elamipretide in a critically ill patient with Barth syndrome.

> PubMed lists PMID 39669625 in Genetics in medicine open as Journal Article, with publication-date metadata of 2024-06-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39669625-elamipretide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-12-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39669625-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39669625-elamipretide-v1.json
- Content SHA-256: `dae65f568203b2e76bf018eaa6f162d7530237217756cb00a79fe0ced491ad19`

## Claims and source pins

### Headline

Expanded-access use of elamipretide in a critically ill patient with Barth syndrome. ([`pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2`](#source-pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2))

### Summary

PubMed lists PMID 39669625 in Genetics in medicine open as Journal Article, with publication-date metadata of 2024-06-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2`](#source-pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2))

### Paragraph 1

PubMed lists PMID 39669625 in Genetics in medicine open as Journal Article, with publication-date metadata of 2024-06-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2`](#source-pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2`](#source-pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2))

## Sources

<a id="source-pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2"></a>
- **Expanded-access use of elamipretide in a critically ill patient with Barth syndrome. · retained source version 1:2024-12-14:current:d054d25c2ef27ac3ecdfea92d93206bee8987c744ddb04cdd151bf6861e0706f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39669625/) (`pubmed-observation-pmid-39669625-2024-12-14-d054d25c2ef2`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Expanded-access use of elamipretide in a critically ill patient with Barth syndrome." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39669625-elamipretide-v1.json SHA-256: dae65f568203b2e76bf018eaa6f162d7530237217756cb00a79fe0ced491ad19.